NASDAQ:XOMA XOMA Royalty Q4 2023 Earnings Report $27.25 +2.48 (+10.01%) Closing price 04:00 PM EasternExtended Trading$27.20 -0.05 (-0.17%) As of 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast XOMA Royalty EPS ResultsActual EPS-$0.49Consensus EPS -$0.36Beat/MissMissed by -$0.13One Year Ago EPSN/AXOMA Royalty Revenue ResultsActual Revenue$1.83 millionExpected Revenue$1.01 millionBeat/MissBeat by +$820.00 thousandYoY Revenue GrowthN/AXOMA Royalty Announcement DetailsQuarterQ4 2023Date3/8/2024TimeN/AConference Call DateFriday, March 8, 2024Conference Call Time7:00AM ETUpcoming EarningsXOMA Royalty's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 7:45 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportConference Call ResourcesPress Release (8-K)Annual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Annual report(10-K) XOMA Royalty Earnings HeadlinesLAVA Therapeutics stock rises on acquisition deal with XOMA RoyaltyAugust 4 at 9:00 AM | investing.comHillevax stock rises after XOMA Royalty announces acquisitionAugust 4 at 9:00 AM | investing.comTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...August 4 at 2:00 AM | InvestorPlace (Ad)XOMA Royalty Corporation Enters Definitive Share Purchase Agreement to Acquire LAVA Therapeutics N.V.August 4 at 7:53 AM | quiverquant.comQHilleVax to be acquired by XOMA RoyaltyAugust 4 at 7:32 AM | seekingalpha.comXOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value RightAugust 4 at 7:30 AM | globenewswire.comSee More XOMA Royalty Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like XOMA Royalty? Sign up for Earnings360's daily newsletter to receive timely earnings updates on XOMA Royalty and other key companies, straight to your email. Email Address About XOMA RoyaltyXOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.View XOMA Royalty ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead? Upcoming Earnings Amgen (8/5/2025)Advanced Micro Devices (8/5/2025)Marriott International (8/5/2025)Aflac (8/5/2025)Arista Networks (8/5/2025)Apollo Global Management (8/5/2025)BP (8/5/2025)Caterpillar (8/5/2025)Coupang (8/5/2025)Duke Energy (8/5/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
